Study of hyperpolarised 3He MRI diffusion on asthma and cystic fibrosis, and development of hyperpolarised 129Xe MRI lung imaging

QR Code

Study of hyperpolarised 3He MRI diffusion on asthma and cystic fibrosis, and development of hyperpolarised 129Xe MRI lung imaging

Hyperpolarised gas Magnetic Resonance Imaging (MRI) is a non-invasive method developed to provide images of the void spaces of the lungs, and evaluate the distal airways via diffusion weighted techniques. The work in this thesis covers the use of both hyperpolarised 3He and hyperpolarised 129Xe gas...

Full description

Bibliographic Details
Main Author:	Hardy, Steven M.
Format:	Thesis (University of Nottingham only)
Language:	English
Published:	2016
Subjects:	MRI Hyperpolarised Helium-3 Xenon-129 Hyperpolarise Cystic Fibrosis Asthma
Online Access:	https://eprints.nottingham.ac.uk/37921/

Similar Items

Production of Hyperpolarised 129Xe for NMR Spectroscopy and Imaging
by: Woolley, Elliot
Published: (2007)

Development of hyperpolarised xenon 129 production and MRI for a clinical setting
by: Irwin, Robert
Published: (2021)

Hyperpolarised xenon production via Rb and Cs optical pumping applied to functional lung MRI
by: Newton, Hayley Louise
Published: (2014)

Characterisation of Rb and Cs spin-exchange optical pumping for application to hyperpolarised 129Xe functional lung MRI
by: Birchall, Jonathan R.
Published: (2017)

Development of upright, multimodal, respiratory MRI
by: Harkin, James
Published: (2020)

Optimisation of xenon-rich stopped-flow spin-exchange optical pumping for functional lung imaging
by: Skinner, J.G.
Published: (2017)

Cryogenics free production of hyperpolarized 129Xe and 83Kr for biomedical MRI applications
by: Hughes-Riley, Theodore, et al.
Published: (2013)

Lung mechanics and hyperpolarised gas MRI
by: Thorpe, James
Published: (2018)

Hyperpolarized Krypton 83Kr as a novel contrast agent for pulmonary magnetic resonance imaging (MRI)
by: Alrumyan, Saleh Abdulkareem A.
Published: (2019)

XeNA: an automated ‘open-source’ 129Xe hyperpolarizer for clinical use
by: Nikolaou, Panayiotis, et al.
Published: (2014)

Functional pulmonary MRI using hyperpolarised 3He
by: Ball, Iain Keith
Published: (2011)

Investigating lung responses with functional hyperpolarized xenon-129 MRI in an ex vivo rat model of asthma
by: Lilburn, David M.L., et al.
Published: (2015)

Molecular MRI with hyperpolarized xenon and smart sensors
by: Hegarty, Ryan Patrick
Published: (2018)

Hyperpolarised noble gas nuclear magnetic resonance and magnetic resonance imaging studies of complex porous media
by: Hill-Casey, Fraser
Published: (2018)

Delayed publications of clinical trials in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2011)

Glutamine supplementation in cystic fibrosis: a randomized placebo-controlled trial
by: Forrester, Doug L., et al.
Published: (2015)

Molecular sensing with hyperpolarized 129Xe using switchable chemical exchange relaxation transfer
by: Zamberlan, Francesco, et al.
Published: (2015)

European Cystic Fibrosis Society standards of care: best practice guidelines
by: Smyth, Alan R., et al.
Published: (2014)

Xbox Kinect™ represents high intensity exercise for adults with cystic fibrosis
by: Holmes, H., et al.
Published: (2013)

Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis
by: Hurley, M.N., et al.
Published: (2012)

Early respiratory bacterial detection and anti-staphylococcal antibiotic prophylaxis in young children with cystic fibrosis
by: Hurley, Matthew, et al.
Published: (2017)

Understanding the Costs of Care for Cystic Fibrosis: an Analysis by Age and Health State
by: Van Gool, K., et al.
Published: (2013)

Cost-Effectiveness of Carrier Screening for Cystic Fibrosis in Australia
by: Norman, Richard, et al.
Published: (2012)

The pharmacokinetics and toxicity of morning vs. evening tobramycin dosing for pulmonary exacerbations of cystic fibrosis: a randomised comparison
by: Prayle, A.P., et al.
Published: (2015)

The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and health care providers
by: Rowbotham, Nicola J., et al.
Published: (2017)

Prevention of treatment related adverse effects in cystic fibrosis
by: Jain, Kamini
Published: (2018)

High prevalence of subclass-specific binding and neutralizing antibodies against Clostridium difficile toxins in adult cystic fibrosis sera: possible mode of immunoprotection against symptomatic C. difficile infection
by: Monaghan, Tanya M., et al.
Published: (2017)

Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis
by: Smyth, Alan R.
Published: (2015)

Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2012)

Working with the patient and clinical community to deliver clinical research in cystic fibrosis. James Lind CF Phase II
by: Smith, S.J., et al.
Published: (2018)

Mitigating the harm caused by Pseudomonas aeruginosa in Cystic Fibrosis
by: Palser, Sally C.
Published: (2024)

Development of a transition readiness scale for young adults with cystic fibrosis: face and content validity
by: Dudman, Lauren, et al.
Published: (2011)

Human Genetics Society of Australasia Position Statement: Population-Based Carrier Screening for Cystic Fibrosis
by: Delatycki, M., et al.
Published: (2014)

Measures of body habitus are associated with lung function in adults with cystic fibrosis: a population-based study
by: Forrester, Doug L., et al.
Published: (2013)

A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patients
by: Elborn, J. Stuart, et al.
Published: (2015)

A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients
by: Flume, Patrick, et al.
Published: (2016)

Molecular mechanisms of enhanced expression of the chemokine interleukin 8 (CXCL8) in cystic fibrosis (CF) airway epithelial cells
by: Poghosyan, Anna
Published: (2014)

Magnetic resonance imaging in respiratory medicine
by: Safavi, Shahideh
Published: (2019)

Surviving and thriving in the cystic fibrosis lung: contribution of an arginine specific aminopeptidase to sustained infection by Pseudomonas aeruginosa
by: Spencer, Daniella Lucy
Published: (2019)

Prescribing practices for intravenous aminoglycosides in UK cystic fibrosis clinics: a questionnaire survey
by: Smyth, Alan R., et al.
Published: (2014)